224 related articles for article (PubMed ID: 18804803)
1. Re: A single instillation of epirubicin after transurethral resection of bladder tumors prevents only small recurrences: I. Berrum-svennung, T. Granfors, S. Jahnson, H. Boman and S. Holmang. J Urol 2008; 179: 101-106.
Oosterlinck W; Sylvester R
J Urol; 2008 Nov; 180(5):2255-6; author reply 2256. PubMed ID: 18804803
[No Abstract] [Full Text] [Related]
2. Feasibility of early intravesical instillation chemotherapy after transurethral resection of the bladder: a prospective evaluation in a consecutive series of 210 cases.
Engeler DS; Wyler S; Neyer M; Hobi C; Müller J; Schmid HP
Scand J Urol Nephrol; 2008; 42(6):522-7. PubMed ID: 18609290
[TBL] [Abstract][Full Text] [Related]
3. A single instillation of epirubicin after transurethral resection of bladder tumors prevents only small recurrences.
Berrum-Svennung I; Granfors T; Jahnson S; Boman H; Holmäng S
J Urol; 2008 Jan; 179(1):101-5; discussion 105-6. PubMed ID: 17997459
[TBL] [Abstract][Full Text] [Related]
4. [Intravesical instillation with epirubicin as a prophylactic treatment for superficial bladder cancer--using two different schedules].
Segawa N; Nishida T; Takahara K; Nomi H; Azuma H; Katsuoka Y
Hinyokika Kiyo; 2008 Nov; 54(11):711-6. PubMed ID: 19068724
[TBL] [Abstract][Full Text] [Related]
5. One immediate postoperative instillation of chemotherapy in low risk Ta, T1 bladder cancer patients. Is it always safe?
Oddens JR; van der Meijden AP; Sylvester R
Eur Urol; 2004 Sep; 46(3):336-8. PubMed ID: 15306104
[TBL] [Abstract][Full Text] [Related]
6. Early and large-dose intravesical instillation of epirubicin to prevent superficial bladder carcinoma recurrence after transurethral resection.
Mitsumori K; Tsuchiya N; Habuchi T; Li Z; Akao T; Ohyama C; Sato K; Kato T
BJU Int; 2004 Aug; 94(3):317-21. PubMed ID: 15291859
[TBL] [Abstract][Full Text] [Related]
7. Comparison of three schedules of intravesical epirubicin in patients with non-muscle-invasive bladder cancer.
Hendricksen K; Witjes WP; Idema JG; Kums JJ; van Vierssen Trip OB; de Bruin MJ; Vergunst H; Caris CT; Janzing-Pastors MH; Witjes JA
Eur Urol; 2008 May; 53(5):984-91. PubMed ID: 18248876
[TBL] [Abstract][Full Text] [Related]
8. [Intravesical instillation of doxorubicin or epirubicin for chemoprophylaxis of superficial bladder cancer--the fifth study of the Japanese Urological Cancer Research Group for Adriamycin/Farumorubicin].
Hinotsu S; Akaza H; Isaka S; Kagawa S; Koiso K; Kotake T; Machida T; Matsumura Y; Niijima T; Obata K; Ohashi Y; Ohe H; Shimazaki J; Tashiro K;
Gan To Kagaku Ryoho; 2002 Jan; 29(1):73-80. PubMed ID: 11816482
[TBL] [Abstract][Full Text] [Related]
9. [Continuous intravesical instillation of epirubicin immediately after transurethral resection of superficial bladder cancer: a prospective controlled study].
Maekawa S; Suzuki H; Ohkubo K; Aoki Y; Okada T; Maeda H; Ogura K; Arai Y
Hinyokika Kiyo; 2000 May; 46(5):301-6. PubMed ID: 10876750
[TBL] [Abstract][Full Text] [Related]
10. Should all patients with non-muscle-invasive bladder cancer receive early intravesical chemotherapy after transurethral resection? The results of a prospective randomised multicentre study.
Gudjónsson S; Adell L; Merdasa F; Olsson R; Larsson B; Davidsson T; Richthoff J; Hagberg G; Grabe M; Bendahl PO; Månsson W; Liedberg F
Eur Urol; 2009 Apr; 55(4):773-80. PubMed ID: 19153001
[TBL] [Abstract][Full Text] [Related]
11. The value of immediate postoperative intravesical epirubicin instillation as an adjunct to standard adjuvant treatment in intermediate and high-risk non-muscle-invasive bladder cancer: A preliminary results of randomized controlled trial.
Elsawy AA; El-Assmy AM; Bazeed MA; Ali-El-Dein B
Urol Oncol; 2019 Mar; 37(3):179.e9-179.e18. PubMed ID: 30448030
[TBL] [Abstract][Full Text] [Related]
12. Intravesical epirubicin treatment following TUR in superficial bladder tumours.
Imamoğlu MA; Bakirtaş H; Yiğitbaşi O; Ersoy H; Sertçelik AN
Arch Esp Urol; 2001 Dec; 54(10):1147-53. PubMed ID: 11852530
[TBL] [Abstract][Full Text] [Related]
13. Re: Richard J. Sylvester, Willem Oosterlinck. An immediate instillation after transurethral resection of bladder tumor in non-muscle-invasive bladder cancer: has the evidence changed? Eur Urol 2009;56;43-5.
Gudjónsson S; Månsson W; Holmäng S; Liedberg F
Eur Urol; 2010 Mar; 57(3):e28-9; author reply e30. PubMed ID: 19931978
[No Abstract] [Full Text] [Related]
14. Epirubicin in treatment and recurrence prophylaxis of patients with superficial bladder cancer.
Burk K; Kurth KH; Newling D
Prog Clin Biol Res; 1989; 303():423-34. PubMed ID: 2780657
[No Abstract] [Full Text] [Related]
15. [Prevention of recurrence of superficial tumors of the bladder with intravesical epirubicin].
Lancina Martín JA; García Pérez M; Arrabal Martín M; Vilches Cocovi E
Actas Urol Esp; 1990; 14(2):112-4. PubMed ID: 2378265
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy and safety of different dosages of intravesical epirubicin instillation for prevention of primary superficial bladder carcinoma from recurrence].
Wu ZB; Lin GB; Chen BJ; Wu ZM; Rong RM
Zhonghua Zhong Liu Za Zhi; 2005 Aug; 27(8):507-9. PubMed ID: 16188156
[TBL] [Abstract][Full Text] [Related]
17. Randomized study of single instillation of epirubicin for superficial bladder carcinoma: long-term clinical outcomes.
Liu B; Wang Z; Chen B; Yu J; Zhang P; Ding Q; Zhang Y
Cancer Invest; 2006 Mar; 24(2):160-3. PubMed ID: 16537185
[TBL] [Abstract][Full Text] [Related]
18. Complications associated with primary and secondary perforation of the bladder following immediate instillations of epirubicin after transurethral resection of superficial urothelial tumours.
Tyritzis SI; Stravodimos KG; Mihalakis A; Constantinides CA
Int Urol Nephrol; 2009 Dec; 41(4):865-8. PubMed ID: 19266307
[TBL] [Abstract][Full Text] [Related]
19. [A randomized study of prophylactic intravesical instillation of pirarubicin (THP) prior to transurethral resection of superficial bladder cancer].
Hashimura T; Shirahase T; Inoue T; Yamasaki T; Terada N; Ogura K; Arai Y; Hida S; Ueda T
Hinyokika Kiyo; 2005 Jul; 51(7):439-42. PubMed ID: 16119805
[TBL] [Abstract][Full Text] [Related]
20. Re: can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy? H. W. Herr, S. M. Donat and G. Dalbagni J Urol 2007; 177: 75-79.
Nieder AM; Soloway MS; Jewett MA
J Urol; 2007 Jul; 178(1):352. PubMed ID: 17507038
[No Abstract] [Full Text] [Related]
[Next] [New Search]
